1. Home
  2. GNFT vs TRAK Comparison

GNFT vs TRAK Comparison

Compare GNFT & TRAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • TRAK
  • Stock Information
  • Founded
  • GNFT 1999
  • TRAK 1990
  • Country
  • GNFT France
  • TRAK United States
  • Employees
  • GNFT N/A
  • TRAK N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • TRAK EDP Services
  • Sector
  • GNFT Health Care
  • TRAK Technology
  • Exchange
  • GNFT Nasdaq
  • TRAK Nasdaq
  • Market Cap
  • GNFT 296.4M
  • TRAK 351.4M
  • IPO Year
  • GNFT 2019
  • TRAK 1998
  • Fundamental
  • Price
  • GNFT $4.50
  • TRAK $21.65
  • Analyst Decision
  • GNFT Strong Buy
  • TRAK Strong Buy
  • Analyst Count
  • GNFT 1
  • TRAK 1
  • Target Price
  • GNFT $13.00
  • TRAK $24.00
  • AVG Volume (30 Days)
  • GNFT 6.3K
  • TRAK 49.6K
  • Earning Date
  • GNFT 09-19-2024
  • TRAK 11-14-2024
  • Dividend Yield
  • GNFT N/A
  • TRAK 0.31%
  • EPS Growth
  • GNFT N/A
  • TRAK 7.98
  • EPS
  • GNFT 0.47
  • TRAK 0.30
  • Revenue
  • GNFT $86,225,222.00
  • TRAK $20,834,350.00
  • Revenue This Year
  • GNFT $155.44
  • TRAK $14.70
  • Revenue Next Year
  • GNFT N/A
  • TRAK $15.00
  • P/E Ratio
  • GNFT $9.31
  • TRAK $72.03
  • Revenue Growth
  • GNFT 175.45
  • TRAK 7.18
  • 52 Week Low
  • GNFT $3.08
  • TRAK $8.94
  • 52 Week High
  • GNFT $6.42
  • TRAK $22.40
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 28.81
  • TRAK 67.71
  • Support Level
  • GNFT $5.10
  • TRAK $18.55
  • Resistance Level
  • GNFT $5.81
  • TRAK $22.40
  • Average True Range (ATR)
  • GNFT 0.21
  • TRAK 0.86
  • MACD
  • GNFT -0.16
  • TRAK 0.17
  • Stochastic Oscillator
  • GNFT 6.13
  • TRAK 80.52

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About TRAK ReposiTrak Inc.

ReposiTrak Inc is a software as a service provider with extensive capabilities that gives their customers an easy, cost-efficient way to expand their services to their benefit. The company and its subsidiaries develop, market, and support proprietary software products. These products assist the management of business operations, which helps clients to make more informed decisions. The company also provides a cloud-based solution to remain in compliance with business records and regulatory requirements. The firm's services comprise implementation, business optimization, outsourcing, technical services, education, and application hosting.

Share on Social Networks: